RADIOPHARMACEUTICALS: TECHNOLOGIES AND GLOBAL MARKETS

Radiopharmaceuticals: Technologies and Global Markets

The global market for radiopharmaceuticals in 2012 was about $3.8 billion and $3.9 billion in 2013. The estimated market for the year 2014 is nearly $4.4 billion and this figure is forecast to expand through 2019 at a projected compound annual growth rate (CAGR) of 8%, approaching $6.4 billion.

This report provides:
-An overview of the global market for radiopharmaceuticals and related technologies.
-Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
-Information on how radiopharmaceuticals are used to diagnose cancer, tumors, brain diseases, bone diseases, bone marrow diseases, colorectal disease, kidney diseases, liver diseases, lung diseases, and many others.
-Details concerning the regulatory environment and the impacts of government on the market.
-Profiles of leading companies in the industry.

INTRODUCTION

STUDY OBJECTIVES
Radiopharmaceuticals play an important role in the medical, pharmaceutical, diagnostic, biotechnology and life sciences industries. A radiopharmaceutical is a radioactive drug used in diagnostics as well as in the treatment of certain medical problems/diseases.

The radiopharmaceuticals market is broadly segmented into two parts, namely, the diagnostic and therapeutic market. North America holds the largest share in the global radiopharmaceuticals market. The objective behind undertaking this study is to provide a synopsis of the current and future characteristics of the global market for radiopharmaceuticals. The notion behind the report is to present a comprehensive analysis of and the future direction for radiopharmaceuticals as an important tool for diagnostics as well as treatment for innumerable diseases.

The report reconnoiters present and future strategies within the radiopharmaceuticals market. The invention of the market, the setbacks and the needs of the market are discussed in this report. A detailed analysis of the radiopharmaceuticals industry structure has been conducted. Revenues are broken down by the region. Sales figures are given for 2012 and 2013, estimated for 2014, and projected for 2019.

Read » Radiopharmaceuticals: Technologies and Global Markets

Published 24 weeks 3 days ago – Made popular 24 weeks 3 days ago
Category: Health | Tags:

Login or register to post comments

Stories similar to Radiopharmaceuticals: Technologies and Global Markets:

Additional information on Radiopharmaceuticals: Technologies and Global Markets :
- radiopharmaceuticals and radionuclides and more than 130 detailed profiles of ... of the world market share whereas more than 50 companies share 14% of this ... While nuclear medicine is not a recent technology, the emergence of new.
- Radiopharmaceuticals: Technologies and Global Markets. Sep 18, 2014 - 19:00 GMT. Information contained on this page is provided by an independent ...
- This BCC Research report covers present and future strategies within the radiopharmaceuticals market along with the invention of the market, the setbacks and ...
- We are a leading provider of sterilization technologies and ... Expand existing product offerings into new global markets; Build on ...
- Analysis of Market Prospects For Therapeutic Radiopharmaceuticals ... has a strong focus on new products and technology and emerging market opportunities . ... parts of the world that are less subject to restrictions applicable to U.S. sources.
- 1 day ago ... The global market for radiopharmaceuticals in 2012 was about $3.8 billion and $3.9 billion in 2013. The estimated market for the year 2014 is ...
- [346 Pages Report] Nuclear Medicine / Radiopharmaceuticals Market report ... Table 13 Global Radiopharmaceutical Diagnostic Market, By Technology, 2010 ...
- Global Radiopharmaceuticals Market to Surpass USD 10 Billion by 2018 There ... technological equipment, increased awareness about radiopharmaceuticals ...

Related links about Radiopharmaceuticals: Technologies and Global Markets :
1. Radiopharmaceuticals: Technologies and Global Markets - WFSB 3 ...
2. Nuclear Medicine / Radiopharmaceuticals Market - Global forecast ...
3. Radiopharmaceuticals: Technologies and Global Markets ...
4. Radiopharmaceuticals: Technologies and Global Markets - PHM171A
5. The Market for Therapeutic Radiopharmaceuticals - BIO-TECH ...

Radiopharmaceuticals Market - Global Industry Analysis 1 year 49 weeks ago

Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and diagnosis of various diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has changed the entire algorithm of disease diagnosis. With rise in the aging population globally coupled with increasing rate of chronic cardiovascular, oncology and neurology diseases, there is tremendous growth potential in this market, especially in developing nations.

Autoimmune Disease Diagnostics: Global Markets 24 weeks 3 days ago

The global market value for autoimmune disease diagnostics for 2013 was valued at $11.9 billion. This is expected to reach about $12.1 billion in 2014 and $13.1 billion in 2019, with a compound annual growth rate (CAGR) of 1.6% for the five-year period, 2014 to 2019.

This report provides:
-An overview of the global market for autoimmune disease diagnostics.
-Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
-Segmentation of the market by disease, by geographical location, and by gender.

Global Markets for Bioengineered Protein Drugs 14 weeks 4 days ago

The global market for bioengineered protein drugs was valued at $151.9 billion in 2013 and will reach about $157.0 billion in 2014. The market is further expected to grow to about $222.7 billion in 2019, a compound annual growth rate (CAGR) of 7.2% from 2014 through 2019.

This report provides:

-An overview of the global market for bioengineered protein drugs.
-Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.

Antibody Drugs: Technologies and Global Markets 3 weeks 2 hours ago

The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2% between 2014 and 2019 resulting in totals nearly $68.9 billion in 2014 and $122.6 billion globally in 2019.

This report provides:
-An overview of the global market for therapeutic monoclonal antibody (mAb) drugs and related applications and technologies.
-Analyses of global market trends, with data from 2012 to 2014, and projections of CAGRs through 2019.

Medical Aesthetic Devices: Technologies and Global Markets 19 weeks 1 day ago

REPORT HIGHLIGHTS

The global market for medical aesthetic devices reached $4.4 billion in 2013 and increasing to $4.6 billion in 2014. This market should reach nearly $6.2 billion in 2019, demonstrating a compound annual growth rate (CAGR) of 5.8% from 2014 to 2019.

This report provides:
-An overview of the global markets and technologies for medical aesthetic devices.
-Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
-Coverage of medical devices including: